Statement of the Federal-Provincial-Territorial Ministers of Health

The Federal, Provincial and Territorial Ministers of Health today issued the following statement at the conclusion of their meeting on Jan. 20 and 21, 2016: “Today, we agreed to move ahead on shared health priorities, working collaboratively while respecting our jurisdictional roles, and guided by the common vision of creating more adaptable, innovative and affordable

Third report from the Health Ministers’ meeting this week in Vancouver B.C.

VANCOUVER, January 22nd, 2016 – Canadian Cancer Survivor Network President and CEO Jackie Manthorne (right) and CCSN Health Policy Consultant Louise Binder (left) were in Vancouver for events taking place around Canada’s Health Ministers meeting. Cancer Patients See Promise in Renewed Collaboration between Federal, Provincial and Territorial Health Ministers The federal, provincial and territorial Health

Second report from the Health Ministers’ meeting this week in Vancouver B.C.

VANCOUVER, January 21st, 2016 – Canadian Cancer Survivor Network President and CEO Jackie Manthorne (left) and CCSN Health Policy Consultant Louise Binder (right) are in Vancouver for events taking place around Canada’s Health Ministers meeting.   Cancer Patient Groups Hopeful Prescription Drug Talks Will Eliminate Existing Drug Access Disparities Across Canada Patient groups attending the

Improving health of Canadians the focus in wide-ranging health talks

VANCOUVER – In a wide-ranging set of discussions touching on many aspects of Canadians' health and health care, provincial and territorial health ministers committed to continued cooperation and collaboration across the country during a meeting today in Vancouver. "My colleagues and I looked at the challenges and opportunities faced by provinces and territories in delivering

Report from the Health Ministers’ meeting this week in Vancouver B.C.

  VANCOUVER, January 20th, 2016 – Canadian Cancer Survivor Network President and CEO Jackie Manthorne and CCSN Health Policy Consultant  Louise Binder are in Vancouver for events taking place around Canada’s Health Ministers meeting. Manthorne and Binder are meeting with several of the Provincial and Territorial Health Ministers to present oncology patients views on important

B.C. health minister says feds to join province’s bulk-buy drug alliance

By The Canadian Press January 19, 2016 11:30 AM VICTORIA – The federal Liberal government is set to join other Canadian provinces and territories in a bulk-buying drug program that aims to lower the cost of prescription medications. British Columbia's Health Minister Terry Lake revealed the news and says federal government participation in the program

Oncology Patient Groups Support Expanded Drug Access

Oncology patient groups support expanded drug access for those forgotten in the health care system because of where they live or lack of income.   We believe that a drug access program, often referred to as pharmacare, must fill the gap for Canadians who do not have adequate financial resources to access existing public systems

BLINCYTO is the First-and-Only Bispecific CD19-Directed CD3 T-Cell Engager (BiTE®) Immunotherapy Approved by Health Canada

Mississauga, ON. (January 12, 2016) – Amgen Canada Inc., today announced that Health Canada has granted conditional* approval of BLINCYTO™ (blinatumomab) for the treatment of adults with Philadelphia chromosome-negative (Ph-) relapsed or refractory B precursor acute lymphoblastic leukemia (ALL). With this approval, BLINCYTO™ becomes the first Health Canada-approved bispecific CD19-directed CD3 T-cell engager (BiTE®) antibody